Tempest Therapeutics Inc.

5.94
0.08 (1.37%)
At close: Apr 11, 2025, 2:00 PM

Tempest Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-41.84M -29.49M -35.71M -28.3M -19.21M -44.57M -27.19M -84.58M -82.26M
389K 381K 638K 374K 339K 1.05M 32K 28K 2.24M
5.3M 2.55M 1.56M 1.1M 453K 310K 1.43M 6.89M 9.21M
8K -2.41M 867K -404K -497K -1.58M 716K -392K 5.75M
1.51M 1.88M 1.57M 1.48M 470K 6.92M 2.22M 67.56M 19.36M
n/a n/a n/a n/a n/a -2.57M n/a n/a n/a
1.61M -2.68M 868K -613K -1.07M -2.05M 1.04M -1.84M 4.58M
-33.03M -27.36M -31.07M -25.96M -19.02M -41.22M -23.65M -20.34M -61.73M
-435K -170K -562K -135K -50K -397K -36K -4K -2.59M
n/a n/a n/a n/a n/a n/a -1.33M 462K n/a
n/a n/a n/a n/a n/a n/a n/a -68.86M -84.42M
n/a n/a n/a n/a n/a 4.38M 2.49M 87.79M 95.1M
n/a n/a n/a 38K 44K n/a 476K -1.45M -1.55M
-435K -170K -562K -97K -6K 3.99M 1.12M 458K 8.1M
-4.4M n/a -4.74M 15M n/a -202K 6.48M -4.46M n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
307K n/a n/a 10.64M -401K 27.14M 33.32M n/a n/a
24.5M 35.6M 11.4M 59.06M 34.6M 26.94M 78.55M -4.46M 54.15M
-8.96M 8.07M -20.23M 33.01M 15.58M -9.82M 55.71M -26.31M 706K
-33.46M -27.53M -31.63M -26.09M -19.07M -41.62M -23.68M -20.34M -64.32M